ATE473739T1 - Verwendung eines benzoyl-derivats von 3- aminocarbazol zur behandlung einer erkrankung im zusammenhang mit der erzeugung von prostaglandin e2 (pge2) - Google Patents

Verwendung eines benzoyl-derivats von 3- aminocarbazol zur behandlung einer erkrankung im zusammenhang mit der erzeugung von prostaglandin e2 (pge2)

Info

Publication number
ATE473739T1
ATE473739T1 AT06753538T AT06753538T ATE473739T1 AT E473739 T1 ATE473739 T1 AT E473739T1 AT 06753538 T AT06753538 T AT 06753538T AT 06753538 T AT06753538 T AT 06753538T AT E473739 T1 ATE473739 T1 AT E473739T1
Authority
AT
Austria
Prior art keywords
aminocarbazole
pge2
prostaglandin
generation
treatment
Prior art date
Application number
AT06753538T
Other languages
English (en)
Inventor
Lorenzo Polenzani
Giorgina Mangano
Isabella Coletta
Maria Alisi
Nicola Cazzolla
Guido Furlotti
Caterina Maugeri
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Application granted granted Critical
Publication of ATE473739T1 publication Critical patent/ATE473739T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
AT06753538T 2005-05-19 2006-05-03 Verwendung eines benzoyl-derivats von 3- aminocarbazol zur behandlung einer erkrankung im zusammenhang mit der erzeugung von prostaglandin e2 (pge2) ATE473739T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000909A ITMI20050909A1 (it) 2005-05-19 2005-05-19 Uso di un benzoil derivato dal 3-ammino-carbazolo per la produzione di un farmaco per il trattamento di un disturbo associato alla produzione di prostaglandina e2-pge2-
PCT/EP2006/004348 WO2006122680A1 (en) 2005-05-19 2006-05-03 Use of a benzoyl derivative of 3-aminocarbazole for the treatment of a disorder associated with the production of prostaglandin e2 (pge2)

Publications (1)

Publication Number Publication Date
ATE473739T1 true ATE473739T1 (de) 2010-07-15

Family

ID=35219704

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06753538T ATE473739T1 (de) 2005-05-19 2006-05-03 Verwendung eines benzoyl-derivats von 3- aminocarbazol zur behandlung einer erkrankung im zusammenhang mit der erzeugung von prostaglandin e2 (pge2)

Country Status (24)

Country Link
US (1) US8686021B2 (de)
EP (1) EP1881826B1 (de)
JP (1) JP5086991B2 (de)
KR (1) KR101312579B1 (de)
CN (1) CN101166528B (de)
AR (1) AR054126A1 (de)
AT (1) ATE473739T1 (de)
AU (1) AU2006246688B2 (de)
BR (1) BRPI0609718A2 (de)
CA (1) CA2604562C (de)
DE (1) DE602006015457D1 (de)
DK (1) DK1881826T3 (de)
EA (1) EA012724B1 (de)
ES (1) ES2347174T3 (de)
GE (1) GEP20094738B (de)
HK (1) HK1119571A1 (de)
IL (1) IL186072A (de)
IT (1) ITMI20050909A1 (de)
MX (1) MX2007013491A (de)
PL (1) PL1881826T3 (de)
PT (1) PT1881826E (de)
SI (1) SI1881826T1 (de)
UA (1) UA94044C2 (de)
WO (1) WO2006122680A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20051523A1 (it) 2005-08-03 2007-02-04 Acraf Composto del 3-ammino-carbazolo composizione farmaceutica che lo contiene e metodo per prepararlo
EP2119705A1 (de) * 2008-05-14 2009-11-18 AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.p.A. 3-Aminocarbazol-Verbindung, pharmazeutische Zusammensetzung damit und Herstellungsverfahren dafür
US8880004B2 (en) 2009-05-14 2014-11-04 Qualcomm Incorporated System and method for resolving conflicts between air interfaces in a wireless communication system

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002241368A (ja) * 1997-02-18 2002-08-28 Shionogi & Co Ltd 新規ベンゾラクタム誘導体およびそれを含有する医薬組成物
US6399631B1 (en) * 1999-07-23 2002-06-04 Pfizer Inc. Carbazole neuropeptide Y5 antagonists
WO2001007409A1 (en) 1999-07-23 2001-02-01 Astrazeneca Uk Limited Carbazole derivatives and their use as neuropeptide y5 receptor ligands
AU769081B2 (en) * 1999-08-26 2004-01-15 Bristol-Myers Squibb Company NPY antagonists: spiroisoquinolinone derivatives
DE10125961A1 (de) * 2001-05-29 2002-12-12 Boehringer Ingelheim Int Carbazolderivate und deren Verwendung zur Herstellung einer Arzneimittelzusammensetzung zur Behandlung von im Zusammenhang mit NPY stehenden Leiden
CA2403307A1 (en) * 2001-10-23 2003-04-23 Neurogen Corporation Substituted 2-cyclohexyl-4-phenyl-1h-imidazole derivatives
KR20030042344A (ko) * 2001-11-22 2003-05-28 한국생명공학연구원 에레모필란계 화합물 또는 곰취추출물을 유효성분으로함유하는 염증질환 치료제, 면역질환 치료제, 및 암 치료제
ES2193875B2 (es) * 2002-04-09 2005-03-01 Laboratorios Del Dr. Esteve, S.A. Derivados de benzoxazinona, su preparacion y su aplicacion como medicamentos.
KR100402714B1 (ko) * 2002-12-23 2003-11-13 한국생명공학연구원 디테르펜계 화합물을 염증질환, 면역질환 및 암 치료제로사용하는 신규한 용도

Also Published As

Publication number Publication date
IL186072A (en) 2012-05-31
PT1881826E (pt) 2010-08-05
AR054126A1 (es) 2007-06-06
MX2007013491A (es) 2008-01-24
CN101166528B (zh) 2011-06-15
CA2604562A1 (en) 2006-11-23
WO2006122680A1 (en) 2006-11-23
ITMI20050909A1 (it) 2006-11-20
SI1881826T1 (sl) 2010-10-29
DE602006015457D1 (de) 2010-08-26
EA012724B1 (ru) 2009-12-30
IL186072A0 (en) 2008-08-07
EA200702534A1 (ru) 2008-04-28
JP2008540591A (ja) 2008-11-20
EP1881826B1 (de) 2010-07-14
KR20080018898A (ko) 2008-02-28
ES2347174T3 (es) 2010-10-26
KR101312579B1 (ko) 2013-09-30
BRPI0609718A2 (pt) 2011-10-18
EP1881826A1 (de) 2008-01-30
CN101166528A (zh) 2008-04-23
US8686021B2 (en) 2014-04-01
JP5086991B2 (ja) 2012-11-28
GEP20094738B (en) 2009-07-27
AU2006246688B2 (en) 2011-09-22
PL1881826T3 (pl) 2010-12-31
HK1119571A1 (de) 2009-03-13
AU2006246688A1 (en) 2006-11-23
UA94044C2 (ru) 2011-04-11
CA2604562C (en) 2013-09-17
DK1881826T3 (da) 2010-11-01
US20080287518A1 (en) 2008-11-20

Similar Documents

Publication Publication Date Title
PE20081201A1 (es) Forma cristalina del hemihidrato de 1-(b-d-glucopiranosil)-4-metil-3-[5-(4-fluorofenil)-2-tienilmetil]benceno
NO20074824L (no) Forlengelse av tid til sykdomsprogresjon eller overlevelse hos kreftpasienter
ATE543512T1 (de) Verwendung von impfstoffen zur behandlung/prävention der übertragung von influenza-erregern zwischen spezies
ATE521352T1 (de) Verwendung von flibanserin zur behandlung von prämenopausalen störungen der sexuellen lust
ECSP099755A (es) Derivados de pirrolopiridina y su uso como inhibidores de bace
EA201071413A1 (ru) Способ и композиция для лечения повышения внутриглазного давления и глаукомы
ATE539743T1 (de) Verfahren zur prävention und behandlung von ppar- vermittelten zuständen mit macelignan
EA201071264A1 (ru) Аминодигидротиазиновые производные в качестве ингибиторов bace для лечения болезни альцгеймера
EA200970402A1 (ru) Триазолопиридазиновые модуляторы протеинкиназ
ATE514435T1 (de) Verwendung eines dpp-iv-hemmers zur minderung hypoglykämischer ereignisse
EA201071099A1 (ru) СОЛЕВЫЕ ФОРМЫ ИНГИБИТОРА mTOR
EA200901573A1 (ru) Гетероарилзамещенные тиазолы
ATE473735T1 (de) Beta-2 adrenoceptor agonisten zur behandlung von bindegewebserkrankungen der haut
ECSP088700A (es) Acidos 4-fenil-tiazol-5-carboxilicos y amidas de acidos 4-fenil-tiazol-5-carboxilicos como inhibidores de la plk1
DE602006013883D1 (de) Verwendung von benzokondensierten heterocyclischen sulfamid-derivaten zur behandlung von depressionen
DE102006060366B8 (de) Verfahren zur Herstellung von von einer Matrix abgedeckten Quantenpunkten
EA200970871A1 (ru) Новое терапевтическое применение 4-[2-(4-метилфенилсульфанил)фенил]пиперидина
ATE439098T1 (de) Implantierbare prothese zur reparatur von herniendefekten
EA201071120A1 (ru) Способ получения гетероарилбензопроизводных сульфаматов и кристаллической формы n-((2s)-6-хлор-2,3-дигидро-l,4-бензодиоксин-2-ил)метилсульфамида
MA32617B1 (fr) Traitement de l'hypertension arterielle pulmonaire
EA201101397A1 (ru) Ингибиторы репликации вируса иммунодефицита человека
ATE473739T1 (de) Verwendung eines benzoyl-derivats von 3- aminocarbazol zur behandlung einer erkrankung im zusammenhang mit der erzeugung von prostaglandin e2 (pge2)
EA201170605A1 (ru) Циклоундекадепсипептидные соединения и применение указанных соединений в качестве лекарственного средства
DE602007011434D1 (de) 1h-indol-5-ylpiperazin-1-ylmethanonderivate
EA201071221A1 (ru) Гетероциклические соединения

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1881826

Country of ref document: EP